Design, synthesis, and biological evaluation of novel thiazole-based CYP1B1 inhibitors to overcome paclitaxel resistance.
Cytochrome P450 1B1 (CYP1B1) is a drug-metabolizing enzyme that is overexpressed in a variety of malignant tumors. Therefore, CYP1B1 has emerged as an important therapeutic target for cancer treatment and the management of drug resistance. In this study, we employed the pharmacophore fusion strategy to optimize the str...